Host translation inhibitor nsp1

UniProt ITasser SWISS Models alphafold D3Targets-2019-nCoV

Inhibits host translation by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome complex further induces an endonucleolytic cleavage near the 5'UTR of host mRNAs, targeting them for degradation. Viral mRNAs are not susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the presence of a 5'-end leader sequence and are therefore protected from degradation. By suppressing host gene expression, nsp1 facilitates efficient viral gene expression in infected cells and evasion from host immune response


Models/PDB

No model built for protein with good structural coverage represented in PDB

Models/PDB Model Chains_ID Selected Templates Model-Quality (MolProbity) PDB Coverage Model Coverage Sequence Length Oligomer States Oligomer Interfaces Model information
nsp1 i 2GDT_A5C5S_A6ZLW_i 1.54 17.77% 100.00% 180 Hetero 35-mer

nsp1

nsp1


Binding Site Predictions

The fpocket calculation in this table only for structure present in the Model/PDB table above.

fpocket pocket score drug score hydrophobicity score polarity score
pocket0_nsp1 32.65 0.24 35.92 6
pocket1_nsp1 27.13 0.01 21.94 5
pocket2_nsp1 26.17 0.06 25.5 8
pocket3_nsp1 25.02 0.02 23.33 5
pocket4_nsp1 22.89 0.02 18.9 6
pocket5_nsp1 22.21 0.01 -16.13 6
pocket6_nsp1 21.42 0.01 5.83 6
pocket7_nsp1 19.85 0.01 13.33 6

UniProt Viewer

Other PDB Hits

ID Method Resolution Å Chains Links
6zme CRYO_EM 3 PDBe
RCSB PDB
6zok CRYO_EM 2.8 PDBe
RCSB PDB
6zlw CRYO_EM 2.7 PDBe
RCSB PDB
6zm7 CRYO_EM 2.7 PDBe
RCSB PDB
6zn5 CRYO_EM 3.2 PDBe
RCSB PDB
6zon CRYO_EM 3 PDBe
RCSB PDB
6zp4 CRYO_EM 2.9 PDBe
RCSB PDB
6zoj CRYO_EM 2.8 PDBe
RCSB PDB
6zmi CRYO_EM 2.6 PDBe
RCSB PDB
6zmo CRYO_EM 3.1 PDBe
RCSB PDB
6zmt CRYO_EM 3 PDBe
RCSB PDB
7k3n X-RAY 1.65 A; PDBe
RCSB PDB
7k5i CRYO_EM 2.9 1; PDBe
RCSB PDB
7k7p X-RAY 1.77 B; PDBe
RCSB PDB


Protein-Protein Interactions

We have mapped SARS CoV-2 human Protein-Protein Interactions from A SARS-CoV-2 protein interaction map reveals targets for drug repurposing human drug target interacted with SARS CoV-2 are highlighted in black arrow.






Responsive image